Njeumi Felix | Epidemiology | Excellence in Research Award

Published on by Global Diseases Research

Excellence in Research Award

Njeumi Felix
Food and Agriculture Organization of the United Nations
Academic Profile
Affiliation Food and Agriculture Organization of the United Nations
Country Italy
Scopus ID 6506444570
Documents 32
Citations 633
h-index 13
Subject Area Epidemiology
Event Global Diseases Research Awards

Njeumi Felix is an epidemiology researcher and international scientific coordinator associated with the Food and Agriculture Organization of the United Nations. His academic and professional activities are primarily connected to infectious disease surveillance, transboundary animal disease control, and global veterinary public health initiatives. His scholarly work reflects contributions to disease eradication programs, epidemiological assessment methodologies, and collaborative international research activities addressing livestock health management and sustainable agricultural development.[1][2]

Abstract

This academic recognition article provides a scholarly overview of Njeumi Felix and his contributions to epidemiology and infectious disease research. His professional activities include research coordination, epidemiological investigations, and participation in global veterinary health initiatives. His scientific work contributes to disease surveillance systems, veterinary public health frameworks, and collaborative international efforts addressing transboundary animal diseases and livestock health management.[1][3]

Keywords

Epidemiology; Veterinary Science; Infectious Diseases; Disease Surveillance; Peste des Petits Ruminants; Global Disease Eradication; Animal Health; Veterinary Public Health; Transboundary Diseases; International Research Collaboration.

Introduction

Epidemiological research plays a significant role in understanding infectious disease transmission and strengthening international disease prevention systems. Veterinary public health initiatives have become increasingly important due to the global impact of transboundary animal diseases on agricultural economies, livestock productivity, and food security. Njeumi Felix has contributed to these scientific and institutional efforts through research coordination, disease surveillance activities, and international collaborative programs.[2]

His academic profile demonstrates involvement in multidisciplinary approaches related to disease eradication frameworks and veterinary epidemiology. These contributions support evidence-based decision-making processes within international animal health management systems.[4]

Research Profile

The research profile of Njeumi Felix reflects scholarly engagement in epidemiology, disease surveillance, and veterinary health management. His Scopus-indexed publication record includes research articles related to infectious disease risk analysis, surveillance strategies, vaccine assessment methodologies, and global disease control initiatives.[1]

His academic activities also indicate substantial international collaboration across scientific institutions and disease control programs. These collaborative efforts contribute to advancing epidemiological understanding and improving veterinary public health infrastructure in multiple geographic regions.[5]

Research Contributions

Njeumi Felix has contributed to research associated with Peste des Petits Ruminants and related transboundary animal diseases. His scientific involvement includes epidemiological modeling, disease risk mapping, surveillance frameworks, and international disease eradication planning activities.[3]

His work additionally supports multidisciplinary veterinary public health approaches integrating scientific research, policy coordination, and institutional collaboration. These contributions strengthen global disease management strategies and support sustainable livestock health systems.[4]

Publications

Selected scientific publications associated with Njeumi Felix include studies addressing epidemiological surveillance, disease risk analysis, vaccine evaluation, and transboundary disease management strategies.[3][4]

  • Risk mapping of Peste des Petits Ruminants virus spread using spatial multicriteria decision analysis methodologies in regions surrounding the Black Sea.[3]
  • Research concerning vaccine thermotolerance criteria for improving disease prevention and veterinary immunization programs.[4]

Research Impact

The scholarly impact of Njeumi Felix is reflected through citation metrics, collaborative publications, and continued participation in global disease research initiatives. His Scopus profile indicates a significant citation record and measurable academic influence within epidemiology and veterinary science research communities.[1]

Beyond academic publication metrics, his work contributes to practical disease management frameworks and international policy-oriented veterinary health programs. These activities support improved livestock health systems and long-term infectious disease mitigation strategies.[2][5]

Award Suitability

Njeumi Felix demonstrates suitability for recognition within the Global Diseases Research Awards due to his sustained contributions to epidemiology, veterinary public health, and infectious disease research. His scholarly activities reflect international collaboration, scientific productivity, and engagement with disease eradication initiatives relevant to global health priorities.[5]

The combination of academic publications, institutional leadership activities, and measurable research impact supports his recognition within international academic and scientific communities focused on disease prevention and epidemiological advancement.[1]

Conclusion

Njeumi Felix has contributed to the advancement of epidemiological research and international veterinary health initiatives through collaborative scientific work and institutional engagement. His academic profile demonstrates ongoing involvement in disease surveillance, infectious disease management, and evidence-based veterinary public health strategies. The impact of his research supports recognition within scholarly platforms dedicated to global disease research and epidemiological studies.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Njeumi Felix, Author ID 6506444570. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6506444570
  2. Food and Agriculture Organization of the United Nations. (n.d.). Global animal health and disease control initiatives. FAO.
    https://www.fao.org/
  3. Arede, M., Beltrán-Alcrudo, D., Benfield, C., Casal, J., & Njeumi, F. (2024). Risk mapping of Peste des Petits Ruminants virus spread in nine countries surrounding the Black Sea: a spatial multicriteria decision analysis approach. Frontiers in Veterinary Science.
    https://doi.org/10.3389/fvets.2026.1783624
  4. Bodjo, C. S., et al. (2023). Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance. Viruses.
    https://doi.org/10.3390/v17091151
  5. Global Diseases Research Awards. (n.d.). International academic recognition and disease research initiatives.
    https://globaldiseases.org/

Ting Cheng | Epidemiology | Research Excellence Award

Published on by Global Diseases Research

Dr. Ting Cheng | Epidemiology | Research Excellence Award

Shanxi Medical University | China

Dr. Cheng Ting is a medical doctor and researcher affiliated with Shanxi Medical University, recognized for her contributions to autoimmune disease research, metabolic disorders, and chronic disease management. Her academic and clinical expertise spans rheumatology, endocrinology, osteoporosis, thyroid disorders, diabetes, and systemic autoimmune diseases. Dr. Cheng has actively contributed to translational medicine through clinical research projects and scientific publications focused on improving diagnosis, treatment, and patient outcomes. She has led provincial and hospital-level research projects and collaborated with national and international scientific communities. Her research achievements include SCI-indexed publications, academic book contributions, and patented medical innovations. Dr. Cheng has also gained international recognition through invited keynote lectures at major conferences, including EULAR and APLAR. Through her dedication to medical advancement, innovation, and patient-centered research, she continues to strengthen biomedical research and healthcare development both nationally and internationally.

Professional Profile

 

Education

Dr. Cheng Ting completed her medical education in China and earned her M.D. qualification with specialized training in internal medicine, autoimmune diseases, endocrinology, and chronic disease management. Her academic background provided extensive knowledge in clinical medicine, biomedical sciences, diagnostic methodologies, and evidence-based healthcare practices. During her advanced medical training, she developed strong expertise in rheumatology, osteoporosis research, metabolic diseases, and immune-related disorders. Her educational journey emphasized both theoretical medical sciences and practical clinical applications, enabling her to integrate patient care with scientific investigation. She further enhanced her academic profile through continuous participation in scientific conferences, professional workshops, and interdisciplinary medical collaborations. Her educational development also includes contributions to academic literature and participation in medical publishing activities. Through continuous learning and professional development, Dr. Cheng has established a strong academic foundation that supports her ongoing research in autoimmune diseases, metabolic health, chronic disease prevention, and translational clinical medicine.

Professional Experience

Dr. Cheng Ting has extensive professional experience in clinical medicine, biomedical research, and chronic disease management. She currently serves at Shanxi Medical University, where she combines patient care with advanced scientific research. Her clinical expertise includes the diagnosis and management of autoimmune diseases, osteoporosis, thyroid disorders, diabetes, and metabolic syndromes. Throughout her career, she has led two provincial and hospital-level research projects aimed at improving treatment strategies and healthcare outcomes. She has authored and co-authored several SCI-indexed research papers and contributed to multiple academic books related to medical sciences. Dr. Cheng also holds numerous national patents, reflecting her commitment to innovation and translational medicine. In addition to research and clinical responsibilities, she has been invited to present keynote speeches at internationally recognized conferences, including EULAR and APLAR. Her professional career demonstrates leadership, scientific excellence, and dedication to advancing global healthcare and medical research.

Research Interest 

Dr. Cheng Ting focuses her research on autoimmune diseases, metabolic disorders, rheumatology, endocrinology, and chronic disease prevention. Her studies investigate the mechanisms, diagnosis, and treatment strategies for conditions such as systemic sclerosis, osteoporosis, thyroid diseases, diabetes, and immune-mediated inflammatory disorders. She is particularly interested in translational medicine approaches that connect laboratory discoveries with clinical applications to improve patient outcomes. Her recent scientific contributions include research on viral infections and autoimmune diseases, as well as the clinical implications of nutritional interventions such as low-carbohydrate diets in autoimmune conditions. Dr. Cheng also emphasizes chronic disease management and preventive healthcare strategies aimed at reducing disease burden and improving long-term quality of life. Through multidisciplinary collaborations and evidence-based research methodologies, she continues to contribute to advancing biomedical science and precision medicine. Her research supports the development of innovative therapeutic approaches and improved healthcare systems for patients with autoimmune and metabolic disorders.

Awards and Honors

Dr. Cheng Ting has received several recognitions for her outstanding contributions to medical research, innovation, and healthcare advancement. One of her most notable achievements is receiving the Second Prize of the Shanxi Provincial Scientific and Technological Progress Award, which honors significant scientific contributions with practical healthcare impact. Her innovative work is further reflected in her ownership of 20 national patents related to medical technologies and healthcare solutions. Dr. Cheng has also earned professional recognition through invitations to deliver keynote speeches at major international and regional scientific conferences, including the European League Against Rheumatism (EULAR) and the Asia Pacific League of Associations for Rheumatology (APLAR). Her academic accomplishments include publishing multiple SCI-indexed papers and contributing to five academic books in the field of medicine and chronic disease management. These honors demonstrate her commitment to scientific innovation, translational medicine, clinical excellence, and international collaboration in biomedical and autoimmune disease research.

Conclusion

Dr. Cheng Ting  is a dedicated clinician, researcher, and innovator whose work significantly contributes to autoimmune disease research, metabolic medicine, and chronic disease management. With strong academic training, clinical expertise, research leadership, and international scientific engagement, she has established herself as an emerging contributor to biomedical and translational medicine. Her achievements include SCI-indexed publications, national patents, prestigious research awards, and keynote presentations at internationally recognized conferences. Dr. Cheng’s commitment to improving healthcare through scientific innovation and evidence-based medicine highlights her growing influence in global medical research. Her continued focus on interdisciplinary collaboration, translational medicine, and patient-centered healthcare positions her for further academic and professional excellence in the international biomedical research community.

Publications Top Noted

  • The application of low-carbohydrate diet in autoimmune diseases: Mechanisms, evidence, and prospects for clinical translation
    Authors: Ming-Fu Lu
    Citation: Autoimmunity Reviews | DOI: 10.1016/j.autrev.2026.104071
  •  Mendelian randomization unveils genetic causal relationships between viral infections and systemic sclerosis
    Authors: Ting Cheng
    Year: 2025
    Citation: Scientific Reports | DOI: Not provided

Daniel Lopez-Hernandez | Public Health | Research Excellence Award

Published on by Global Diseases Research

Dr. Daniel Lopez-Hernandez | Public Health | Research Excellence Award

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | Mexico

Dr. Daniel López-Hernández is a researcher affiliated with the Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico, with expertise rooted in applied medical and health sciences that support evidence-based public health and clinical practice. He has authored 16 peer-reviewed publications, which together have received 361 citations, reflecting the relevance and visibility of his work within the scientific community. With an h-index of 7, his research demonstrates consistent scholarly impact and influence. Dr. López-Hernández has collaborated with over 40 co-authors, highlighting strong interdisciplinary and international research engagement. His contributions address real-world health challenges, strengthening healthcare delivery systems and informing policy and clinical decision-making. Through sustained research productivity and collaboration, his work contributes to improving health outcomes and advancing medical knowledge with tangible societal benefit.

Citation Metrics (Scopus Preview)

361
270
180
`16
0

Citations

361

Documents

16

h-index

7

Citations

Documents

h-index

Note: h-index details are disabled in Scopus Preview mode.

View Scopus Profile   View Google Scholar Profile
Top 5 Featured Publications

Huijun Guo | Prevention | Top HIV/AIDS Research Award

Published on by Global Diseases Research

Prof. Huijun Guo | Prevention | Top HIV/AIDS Research Award

Henan University of Chinese Medicine | China

Prof. Huijun Guo is a scholar at Henan University of Chinese Medicine, Zhengzhou, China, with recognized expertise in infectious diseases, epidemiology, and evidence-based clinical research, particularly focused on HIV, chronic hepatitis B, Helicobacter pylori infection, and immune-related disorders. He has authored 54 Scopus-indexed publications, which have collectively received 272 citations, reflecting the steady academic influence of his work, and holds an h-index of 10. His research is characterized by high-impact systematic reviews, meta-analyses, and longitudinal cohort studies published in leading international journals such as BMJ Open, Frontiers in Medicine, and the World Journal of Gastroenterology. Prof. Guo has collaborated extensively with a broad international network of researchers, contributing to translational insights that inform clinical practice and public health policy. His work supports improved disease management strategies and strengthens evidence-based healthcare decision-making with clear societal relevance.

Citation Metrics (Scopus)

272
200
150
80
0

Citations

272

Documents

54

h-index

10

Citations

Documents

h-index

View Scopus Profile

Top 5 Featured Publications

Jin Hu | Public Health | Excellence in One Health Research

Published on by Global Diseases Research

Dr. Jin Hu | Public Health | Excellence in One Health Research 

Tsinghua School of Medicine | China

Dr. Jin Hu is an Associate Professor at the Tsinghua School of Medicine, Beijing, China, with established expertise in biomedical and translational medical research. The author has published 14 peer-reviewed documents indexed in Scopus, receiving 985 citations and achieving an h-index of 12, reflecting consistent scholarly impact. Research contributions are recognized internationally through collaboration with 36 co-authors across interdisciplinary teams, supporting innovation in medical science and evidence-based healthcare. Hu Jin’s work advances scientific understanding with practical relevance, contributing to improved research capacity, knowledge dissemination, and long-term societal benefits in health and medicine at both national and global levels.

Citation Metrics (Scopus)

985
740
500
250
0

Citations

985

Documents

14

h-index

12

Citations

Documents

h-index

View Scopus Profile

Top 5  Featured Publications

Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award

Published on by Global Diseases Research

Dr. Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award 

Lecturer | Univeristy of the Witwatersrand | South Africa

Dr. Raeesa Manjoo-Docrat is a developing scholar affiliated with the University of the Witwatersrand, Johannesburg, whose work contributes to the advancement of quantitative epidemiology and public health modelling in South Africa. Her research focuses on the development and application of spatial, age-stratified epidemiological models aimed at understanding disease transmission dynamics within heterogeneous populations. With four peer-reviewed publications and 27 citations, she has established a growing academic footprint supported by an h-index of 2, reflecting the early but significant influence of her work. Her recent open-access article in Heliyon (2025), which applies spatial modelling frameworks to the South African COVID-19 pandemic, exemplifies her commitment to integrating mathematical rigor with real-world public health challenges. Manjoo-Docrat has collaborated with multidisciplinary teams comprising epidemiologists, mathematicians, and public health scientists, enabling her to contribute to robust analytical frameworks and high-quality scientific outputs. These collaborations also highlight her ability to operate effectively within diverse research environments and to engage in evidence-based problem solving that supports both academic and policy-relevant outcomes. Her research sits at the intersection of infectious disease dynamics, health systems planning, and data-driven decision support, positioning her work within a globally relevant domain of applied epidemiology. Beyond academic metrics, her contributions have societal impact by informing approaches to epidemic preparedne  ss, guiding interventions for vulnerable demographic groups, and enhancing understanding of spatial disparities in health outcomes. Through her continued scholarship, Manjoo-Docrat aims to strengthen the integration of mathematical modelling into national and regional public health strategies, ensuring that data-informed insights contribute to improved health resilience and equitable disease control.

Profiles: Scopus | ORCID

Featured Publications

1. Manjoo-Docrat, R., Abdelatif, N., Holloway, J., Dudeni-Tlhone, N., Dresselhaus, C., Mbayise, E., … Makhanya, S. (2025). Spatial age-stratified epidemiological model with applications to South African COVID-19 pandemic. Heliyon, 11(11), e43171. https://doi.org/10.1016/j.heliyon.2025.e43171

2. Dresselhaus, C., Fabris-Rotelli, I., Manjoo-Docrat, R., Brettenny, W., Holloway, J., Thiede, R., Debba, P., & Dudeni-Tlhone, N. (2023). A spatial model with vaccinations for COVID-19 in South Africa. Spatial Statistics, 58, Article 100792. Cited by 2.

3. Manjoo-Docrat, R. (2022). A spatio-stochastic model for the spread of infectious diseases. Journal of Theoretical Biology, 533, 110943.  Cited by 16.

4. Fabris-Rotelli, I., Holloway, J., Kimmie, Z., Archibald, S., Debba, P., Manjoo-Docrat, R., … Potgieter, A. (2022). A Spatial SEIR Model for COVID-19 in South Africa. Journal of Data Science, Statistics, and Visualisation, 2(7), 14–45.  Cited by 5.

Qingju Zhang | Vaccines | Best Researcher Award

Published on by Global Diseases Research

Prof. Qingju Zhang | Vaccines | Best Researcher Award 

Researcher | Jiangxi Normal University | China

Prof. Qingju Zhang is a distinguished researcher at Jiangxi Normal University, China, recognized for her significant contributions to synthetic carbohydrate chemistry, glycoscience, and vaccine-related glycoconjugate development. With a portfolio of 44 peer-reviewed publications and over 870 citations across 632 citing documents, she has established a strong scholarly footprint marked by methodological innovation, collaborative strength, and impactful research outputs. Her work focuses on the chemical synthesis, structural modification, and functional exploration of complex oligosaccharides, especially those relevant to pathogenic bacteria such as Acinetobacter baumannii and Bordetella hinzii. Recent publications highlight her leadership in advancing direct glycosylation methods, visible-light-mediated stereoselective transformations, and halogen/hydrogen-bond-assisted activation strategies, reflecting her expertise in contemporary reaction design and mechanistic insight. Her research on carbohydrate-based vaccines exemplifies a translational vision aimed at developing effective immunogens targeting antibiotic-resistant bacterial pathogens. With an h-index of 16 and a network of over 110 international and interdisciplinary co-authors, she collaborates widely across chemistry, microbiology, and biomedical science communities, underscoring her role as a key contributor to global glycoscience research. In addition to pioneering synthetic methodologies, her work advances fundamental understanding of bacterial O-antigen structures and supports the design of next-generation vaccine candidates with potential societal benefits in infectious disease control. Through consistent scholarly productivity, rigorous experimental approaches, and high-impact publications in leading journals such as ACS Catalysis, Organic Letters, and JACS Au, Prof. Zhang continues to enrich the field of carbohydrate chemistry while fostering scientific collaborations that bridge basic research and biomedical application.

Profiles: Scopus | ORCID

Featured Publications

1. Wang, L., Chen, M., Zou, J., Wu, S., Guo, K., Liu, D., Liu, C., Wang, Z., Hansen, T., & Zhang, Q. (2025, August 15). Direct glycosylation of N,N-dimethyl amino sugars via halogen/hydrogen-bonding interactions. ACS Catalysis, 15, 14115–14126. 
Cited by: 1

2. Wang, L., Li, X., Duan, L., Liu, D., Qi, J., & Zhang, Q. (2025, June). Fragments synthesis of Acinetobacter baumannii ATCC 17961 O-Antigen. Synlett.

3. Zhang, Y., Liu, C., & Zhang, Q. (2025, May 23). Recent advances of carbohydrate-based vaccines against Acinetobacter baumannii. European Journal of Organic Chemistry.

4. Zhang, L., Zheng, Z., Zhang, Y., Wu, X., Tu, Y., Liu, C., Wang, Z., Wang, L., Yang, Y., & Zhang, Q. (2025, April 28). Chemical synthesis and antigenic evaluation of oligosaccharides of Bordetella hinzii O-Antigen containing unique amidated 2,3-diacetamido-2,3-dideoxy-alduronic acids. JACS Au, 5, 1903–1913. 
Cited by: 4

5. Wang, Z., Poveda, A., Zhang, Q., Unione, L., Overkleeft, H. S., van der Marel, G. A., & Codée, J. D. C. (2023, June 28). Total synthesis and structural studies of zwitterionic Bacteroides fragilis polysaccharide A1 fragments. Journal of the American Chemical Society. 
Cited by: 15

Fangfang Tao | Chikungunya Virus | Best Researcher Award

Published on by Global Diseases Research

Prof. Dr. Fangfang Tao | Chikungunya Virus | Best Researcher Award 

Zhejiang Chinese Medical University | China

Prof. Dr. Fangfang Tao is a dedicated researcher at Zhejiang Chinese Medical University whose work spans integrative medicine, public health, and translational biomedical science. With a portfolio of 35 peer-reviewed publications and over 380 citations, Dr. Tao has established a growing scholarly presence supported by an h-index of 11, reflecting consistent influence and research quality. Her contributions often integrate traditional Chinese medical principles with modern clinical and epidemiological approaches, advancing evidence-based understanding of disease mechanisms, therapeutic strategies, and patient-centered health outcomes. Dr. Tao’s collaborative record is extensive, with partnerships involving more than 100 co-authors across national and international institutions, demonstrating her commitment to interdisciplinary inquiry and global scientific engagement. Her work contributes meaningfully to emerging health challenges by prioritizing rigorous methodology, culturally relevant medical insights, and innovative therapeutic frameworks. Through her research, Dr. Tao aims to bridge traditional medical knowledge with contemporary biomedical science to enhance clinical practice, inform health policy, and promote accessible, effective care. Her scholarly achievements underscore not only a strong trajectory in academic research but also a broader societal impact, as her studies support improved diagnostic approaches, better-targeted interventions, and enhanced patient well-being across diverse populations.

Profiles: Scopus | Google Scholar

Featured Publications

1. Niu, N., Zhang, J., Zhang, N., Mercado-Uribe, I., Tao, F., Han, Z., Pathak, S., … (2016). Linking genomic reorganization to tumor initiation via the giant cell cycle. Oncogenesis, 5(12), e281.
Cited by: 169

2. Tao, F., Tian, X., Ruan, S., Shen, M., & Zhang, Z. (2018). miR‐211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma. The FASEB Journal, 32(11), 6330–6343.
Cited by: 92

3. Tao, F., Tian, X., Lu, M., & Zhang, Z. (2018). A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c. Journal of Genetics and Genomics, 45(3), 137–145.
Cited by: 59

4. Tian, X., Tao, F., Zhang, B., Dong, J. T., & Zhang, Z. (2018). The miR‐203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK‐3β/β-catenin signal pathway. IUBMB Life, 70(3), 224–236.
Cited by: 42

5. Jiang, X., Cui, X., Xu, H., Liu, W., Tao, F., Shao, T., Pan, X., & Zheng, B. (2019). Whole genome sequencing of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from a wastewater treatment plant in China. Frontiers in Microbiology, 10, 1797.
Cited by: 34

LI Ruixiang | Epidemiology | Editorial Board Member

Published on by Global Diseases Research

Mrs. LI Ruixiang | Epidemiology | Editorial Board Member

Professor | Affiliated Hospital of Shandong Second Medical University | China

Mrs. Li Ruixiang is an emerging researcher whose work advances maternal–child health, neonatal nutrition, and early-life growth assessment through rigorous quantitative and engineering-informed methodologies. Her scholarship includes key contributions to understanding threshold effects of third-trimester maternal vitamin A status on neonatal ponderal index, published in Food Science & Nutrition, and the development of computer-assisted methods for evaluating early physical linear growth among small-for-gestational-age infants, featured in the Journal of Healthcare Engineering. These studies demonstrate her ability to integrate biomedical knowledge with advanced analytical approaches, generating evidence that supports more precise assessment of neonatal growth patterns and micronutrient-related developmental outcomes. Mrs. Li’s collaborative work with multidisciplinary teams—comprising nutritionists, paediatric clinicians, biomedical engineers, and public health experts—reflects her commitment to methodological innovation and translational research. Although still in the early stages of her academic career, she has contributed to a growing body of literature that strengthens global understanding of neonatal anthropometry, maternal nutrition, and data-driven modelling in child health. Her findings help inform clinical decision-making, contribute to improved detection of growth abnormalities, and support public health policies aimed at reducing early-life vulnerabilities. Through her focused research agenda and evidence-based analyses, Mrs. Li Ruixiang continues to build a research profile with meaningful societal relevance and potential for long-term impact on maternal and neonatal wellbeing.

Profiles: ORCID

Featured Publications

1. Ji, J., Cui, L., Ni, J., & Li, R. (2025). Threshold Effects of Third-Trimester Maternal Vitamin A on Neonatal Ponderal Index: A Segmented Regression Analysis of 442 Mother–Infant Pairs. Food Science & Nutrition.

2. Li, R., Yin, M., Cui, L., Zheng, R., & Malik Alazzam. (2021). Early Physical Linear Growth of Small-for-Gestational-Age Infants Based on Computer Analysis Method. Journal of Healthcare Engineering. Citations: 4

Through innovative analytical methods and population-level studies, the nominee illuminates critical nutritional thresholds that influence infant development. Their work strengthens scientific understanding and guides public health strategies that enhance early-life health across diverse communities.

Ashenafi Gebremarian | Public Health | Editorial Board Member

Published on by Global Diseases Research

Assoc. Prof. Dr. Ashenafi Gebremarian | Public Health | Editorial Board Member

Huazhong Agricultural University | China

Assoc. Prof. Dr. Ashenafi Gebremariam is an emerging scholar and academic professional at Huazhong Agricultural University, Wuhan, China, recognized for his early yet growing contributions to agricultural and veterinary sciences. His Scopus-indexed research portfolio includes two peer-reviewed publications supported by two citations, reflecting the initial stages of academic impact and the steady visibility of his work in global scholarly circles. With an h-index of 1, he demonstrates a developing research trajectory that is expanding through specialized studies in animal health, agricultural biotechnology, and related life-science disciplines. Dr. Gebremariam’s collaboration with at least eight co-authors signals his active engagement in multidisciplinary research environments and underscores his commitment to knowledge exchange, methodological rigor, and international scientific cooperation. His academic affiliation with a leading agricultural institution places him at the forefront of research aimed at enhancing food security, livestock productivity, and sustainable agricultural systems. Although his publication record is still in its formative phase, his contributions reflect a clear dedication to generating evidence-based insights that address societal needs, support innovation, and strengthen global agricultural resilience. As his research continues to evolve, Assoc. Prof. Dr. Gebremariam is positioned to expand his scholarly influence through high-quality publications, impactful collaborations, and continued advancement in the fields of veterinary and agricultural sciences.

Profiles: Scopus | ORCID

Featured Publications

1.Shi, Y., Peng, G., Gebremariam, A. A., Iqbal, M. M., Baghaei Daemi, H., Khan, M. A., Ullah, R., & Wang, D. (2024). Analytical insights, modulation and compositional dynamics of the feline gut microbiota: a review. Animal Diseases, Article 00140. Cited by: 2.

2. Fentie, T., Teshome, Y., Ayele, B., Molla, W., Fenta, N., Nigatu, S., Assefa, A., & Leta, S. (2018). Sero-epidemiological study of peste des petits ruminants in small ruminants in Amhara region, Ethiopia. Comparative Clinical Pathology, 27(4), 1029–1036. https://doi.org/10.1007/s00580-018-2697-2 — Cited by: 15.

3. Fentie, T., Fenta, N., Leta, S., Molla, W., Ayele, B., Teshome, Y., Nigatu, S., & Assefa, A. (2017). Sero-prevalence, risk factors and distribution of sheep and goat pox in Amhara Region, Ethiopia. BMC Veterinary Research, 13, Article 385. https://doi.org/10.1186/s12917-017-1312-0 — Citation count not reliably available from publicly accessible sources at this time

Assoc. Prof. Dr. Ashenafi Gebremariam advances veterinary and agricultural science through research that strengthens animal health, productivity, and sustainable livestock systems. His work contributes to improved disease understanding and supports innovations that enhance food security and the resilience of global animal agriculture.